{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreia3wpbmcfgromc2zadi2pocxdxposw3nnxu5nhk6ywu4xp2s5hp4i",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mo2qsaza2bn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicmgfq2jzzuyl32dkm3u3pi3wpusvv5cxitcmhxuohb3p4bphwwdq"
    },
    "mimeType": "image/jpeg",
    "size": 119758
  },
  "path": "/news/2026-06-ada-glucose-lowers-hba1c-adults.html",
  "publishedAt": "2026-06-11T21:40:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study presented at the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.",
  "title": "ADA: Continuous glucose monitoring lowers HbA1c in adults with type 2 diabetes not on insulin"
}